We are live on ! Find out more
ENGNW icon

enGene Therapeutics Warrants
ENGNW

17 hedge funds and large institutions have $3.29M invested in enGene Therapeutics Warrants in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 3 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more funds holding

Funds holding: 15 → 17 (+2)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

1.75% less ownership

Funds ownership: 45.73% → 43.97% (-1.8%)

11% less capital invested

Capital invested by funds: $3.7M → $3.29M (-$411K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
17
Holders Change
+2
Holders Change %
+13.33%
% of All Funds
0.22%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
2
Increased
–
Reduced
3
Closed
–
Calls
$49K
Puts
–
Net Calls
+$49K
Net Calls Change
-$8K

Top Buyers

Rank Fund Capital Flow
1
WAM
Wolverine Asset Management
Illinois
+$45K
2
CM
Caption Management
Oklahoma
+$5.41K

Top Sellers

Rank Fund Capital Flow
1
OFM
Omega Fund Management
Massachusetts
-$176K
2
UBS Group
UBS Group
Switzerland
-$9.82K
3
State of Wisconsin Investment Board
State of Wisconsin Investment Board
Wisconsin
-$3.43K
Name Holding Trade Value Shares
Change 		Change in
Stake
FIS
1
FCPM III Services
Netherlands
$2.07M – – –
BI
2
BVF Inc
California
$681K – – –
SCM
3
Saba Capital Management
New York
$128K – – –
Calamos Advisors
4
Calamos Advisors
Illinois
$108K – – –
D.E. Shaw & Co
5
D.E. Shaw & Co
New York
$75.3K – – –
OFM
6
Omega Fund Management
Massachusetts
$63.4K -$176K -231,800 -72%
WAM
7
Wolverine Asset Management
Illinois
$42.2K +$45K +59,431 New
TCM
8
Tenor Capital Management
New York
$39.2K – – –
BOCH
9
Blue Owl Capital Holdings
New York
$25.6K – – –
WA
10
Whitebox Advisors
Minnesota
$22K – – –
State of Wisconsin Investment Board
11
State of Wisconsin Investment Board
Wisconsin
$13.7K -$3.43K -4,521 -19%
CL
12
CSS LLC
Illinois
$12K – – –
CM
13
Caption Management
Oklahoma
$5.07K +$5.41K +7,144 New
UBS Group
14
UBS Group
Switzerland
$4.76K -$9.82K -12,958 -66%
Bank of America
15
Bank of America
North Carolina
$213 – – –
CS
16
Clear Street
New York
$213 – – –
Toronto Dominion Bank
17
Toronto Dominion Bank
Ontario, Canada
$72 – – –

ENGNW Hedge Fund Activity: Q3 2025 in Review

17 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in enGene Therapeutics Warrants (ENGNW) for Q3 2025, worth a combined $3.29M — down 11% from $3.7M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new ENGNW positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 3 trimmed.

The largest buyer was Wolverine Asset Management, opening a new position worth an estimated $45K. The largest seller was Omega Fund Management, cutting an estimated $176K.

  • 17 institutional investors held enGene Therapeutics Warrants (ENGNW) as of Q3 2025, up from 15 in Q2 2025.
  • Funds reported $3.29M of enGene Therapeutics Warrants stock for Q3 2025, down 11% quarter-over-quarter.
  • 2 funds opened new enGene Therapeutics Warrants positions in Q3 2025 and 0 closed out, a net change of +2 holders.
  • The largest enGene Therapeutics Warrants buyer in Q3 2025 was Wolverine Asset Management, an estimated $45K added.
  • The largest enGene Therapeutics Warrants seller in Q3 2025 was Omega Fund Management, an estimated $176K sold.

Based on aggregated 13F filings for Q3 2025.